Simplify Propel Opportunities ETF
 
 
 
 
基本資料
種類: ETF
費用比率%: 2.56
資產淨值: 16.99
成立日期: 07/02/2023
 
分析
市值分佈:
38.49%
大市值
15.33%
中市值
36.87%
小市值
持股比例加總可能不達100%,原因包括ETF持有現金或衍生工具。
 
 
行業分佈 國家/地區分佈
 
投資組合
 (更新時間: 07/03/2026 05:58) 總持有投資項目: 34  
0%
 
100%
     10大 (69.10%)
代號 名稱 佔比% 持有日期
PAGPPlains GP Holdings LP36.7627/02/2026
ACHVAchieve Life Sciences6.9227/02/2026
PHATPhathom Pharmaceuticals4.9327/02/2026
MISTMilestone Pharmaceuticals3.3027/02/2026
ABEOAbeona Therapeutics3.2827/02/2026
CLDXCelldex Therapeutics3.2827/02/2026
DCTHDelcath Systems2.9827/02/2026
OCSOculis Holding AG2.7927/02/2026
VRDNViridian Therapeutics2.7527/02/2026
IVAInventiva SA2.1127/02/2026
KYTXKyverna Therapeutics2.0227/02/2026
CORTCorcept Therapeutics1.7327/02/2026
LENZLENZ Therapeutics1.5927/02/2026
FDMT4D Molecular Therapeutics1.4227/02/2026
CMPSCOMPASS Pathways Plc1.4127/02/2026
ZVRAZevra Therapeutics1.3627/02/2026
KLRSKalaris Therapeutics Inc1.1727/02/2026
TRVITrevi Therapeutics1.1127/02/2026
SABSSAB Biotherapeutics1.0927/02/2026
LONALeonaBio Inc.1.0827/02/2026
 1    2  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.